johnson and johnson glp-1 Readout Newsletter: & Johnson, Pfizer's GLP-1, more Prescription GLP-1s for Weight Loss
Description
highly biased toward individuals experiencing issues
Brandt et al., 2019
When to Check In With Your Doctor 8 Ways to Fight Back Against GLP-1 Fatigue 1
For instance, patients with non-exudative AMD and metabolic risk factors may be ideal candidates, while those with nAMD may require caution and close monitoring if systemic GLP-1RA therapy is initiated for metabolic reasons
